These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 38199443)
1. J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice. Pan Z; Shao M; Zhao C; Yang X; Li H; Cui G; Liang X; Yu CW; Ye Q; Gao C; Di L; Chern JW; Zhou H; Lee SM Eur J Pharm Sci; 2024 Mar; 194():106696. PubMed ID: 38199443 [TBL] [Abstract][Full Text] [Related]
2. Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo. Shao M; Zhao C; Pan Z; Yang X; Gao C; Kam GH; Zhou H; Lee SM Chem Biol Interact; 2024 Nov; 403():111224. PubMed ID: 39233265 [TBL] [Abstract][Full Text] [Related]
3. Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome. Pan Z; Yu CW; Zhao C; Shao M; Yang X; Liang X; Li H; Lu Y; Ye Q; Chern JW; Lu J; Zhou H; Lee SM Toxicol Appl Pharmacol; 2023 Dec; 480():116745. PubMed ID: 37931757 [TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease Zhou H; Shao M; Yang X; Li C; Cui G; Gao C; Di L; Zhong H; Wang Y; Zhang Z; Lee SM Oxid Med Cell Longev; 2019; 2019():8169125. PubMed ID: 31827703 [TBL] [Abstract][Full Text] [Related]
5. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice. Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613 [TBL] [Abstract][Full Text] [Related]
6. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease. Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802 [TBL] [Abstract][Full Text] [Related]
7. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway. Huang W; Wang Y; Huang W Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926 [TBL] [Abstract][Full Text] [Related]
8. Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway. Liu J; Jiang J; Qiu J; Wang L; Zhuo J; Wang B; Sun D; Yu S; Lou H Food Funct; 2022 Jan; 13(1):375-385. PubMed ID: 34905594 [TBL] [Abstract][Full Text] [Related]
9. Buyang Huanwu Decoction Vigorously Rescues PC12 Cells Against 6-OHDA-Induced Neurotoxicity via Akt/GSK3β Pathway Based on Serum Pharmacology Methodology. Li Z; Wang H; Wang Q; Sun J Rejuvenation Res; 2016 Dec; 19(6):467-477. PubMed ID: 26935342 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease. Ay M; Luo J; Langley M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG J Neurochem; 2017 Jun; 141(5):766-782. PubMed ID: 28376279 [TBL] [Abstract][Full Text] [Related]
11. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway. Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399 [TBL] [Abstract][Full Text] [Related]
12. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice. Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease. Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo neuroprotective effect of novel mPGES-1 inhibitor in animal model of Parkinson's disease. Yang S; Huh E; Moon GH; Ahn J; Woo J; Han HS; Lee HH; Chung KS; Lee KT; Oh MS; Lee JY Bioorg Med Chem Lett; 2022 Oct; 74():128920. PubMed ID: 35931244 [TBL] [Abstract][Full Text] [Related]
15. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties. Olatunji OJ; Feng Y; Olatunji OO; Tang J; Ouyang Z; Su Z Biomed Pharmacother; 2016 Jul; 81():7-14. PubMed ID: 27261571 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease. Eo H; Kwon Y; Huh E; Sim Y; Choi JG; Jeong JS; Du XF; Soh HY; Hong SP; Kim Pak Y; Oh MS Biomed Pharmacother; 2019 Sep; 117():109184. PubMed ID: 31387167 [TBL] [Abstract][Full Text] [Related]
17. Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells. Guo L; Qu B; Song C; Zhu S; Gong N; Sun J J Affect Disord; 2022 Nov; 316():233-242. PubMed ID: 35981627 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model. Ferreira AFF; Singulani MP; Ulrich H; Feng ZP; Sun HS; Britto LR Mol Neurobiol; 2022 Mar; 59(3):1543-1559. PubMed ID: 35000153 [TBL] [Abstract][Full Text] [Related]
19. Lee DW; Ryu YK; Chang DH; Park HY; Go J; Maeng SY; Hwang DY; Kim BC; Lee CH; Kim KS J Microbiol Biotechnol; 2022 Sep; 32(9):1168-1177. PubMed ID: 36168204 [TBL] [Abstract][Full Text] [Related]
20. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Ayadi AE; Zigmond MJ; Smith AD Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]